PNV looks like the can advance their company without a partnership for BTM. That is quite an achievement, quite special. Big pharma has no obvious leverage, they don't need cash.
Ann: Appendix 3B Leon Hoare, page-18
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.55 |
Change
-0.030(1.16%) |
Mkt cap ! $1.760B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.61 | $2.55 | $1.647M | 639.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 847 | $2.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.56 | 3376 | 1 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |